Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
11/14/2013 | WO2013168876A1 Kit for monitoring immune status after transplant and monitoring method using same |
11/14/2013 | WO2013168859A1 Method for discovering biomarkers |
11/14/2013 | WO2013168851A1 Inspection system integrating real-time polymerase chain reaction and dna chip, and integrated analysis method using same |
11/14/2013 | WO2013168844A1 Method for detecting genes sensitive to low-level ionizing radiation, and gene detected by the method |
11/14/2013 | WO2013168826A1 Method for screening for prophylactic or therapeutic agent for diseases or disorders associated with inflammation-related feedback loop |
11/14/2013 | WO2013168820A1 Anti-cxadr antibody |
11/14/2013 | WO2013168767A1 Process for removing red blood cells and centrifugal tube for blood collection |
11/14/2013 | WO2013168765A1 Method for detecting reaction |
11/14/2013 | WO2013168695A1 Method for measuring organism-originated physiologically active substance in hyaluronic acid preparation |
11/14/2013 | WO2013168602A1 Method for detecting disseminated intravascular coagulation or infectious disseminated intravascular coagulation |
11/14/2013 | WO2013168550A1 Cancer immunotherapy evaluation method, cancer immunotherapy evaluation device, cancer immunotherapy evaluation program, cancer immunotherapy evaluation system, and information communication terminal device |
11/14/2013 | WO2013168482A1 Fertilizing amount setting method, fertilizing amount setting device, and fertilizing amount setting program |
11/14/2013 | WO2013168395A2 Microchip for nucleic acid analysis |
11/14/2013 | WO2013168390A1 Biological information measurement device and biological information measurement method using same |
11/14/2013 | WO2013168097A1 Equipment and method to determine the permeability of fruit cuticles in vivo |
11/14/2013 | WO2013167960A1 Ore analysis system |
11/14/2013 | WO2013167727A2 Method for determining arthritis relapse risk |
11/14/2013 | WO2013167668A1 Electrochemical detection of polymerase reactions by specific metal-phosphate complex formation |
11/14/2013 | WO2013167620A1 Immunomodulatory methods using notch agonists |
11/14/2013 | WO2013167587A1 Intra-operative cancer diagnosis based on a hyperpolarized marker |
11/14/2013 | WO2013167582A1 Methods and pharmaceutical compositions for prevention or treatment of chronic obstructive pulmonary disease |
11/14/2013 | WO2013167150A1 Reagent for clarifying emulsions and method of clarification |
11/14/2013 | WO2013166898A1 A test strip for reading by an electric reading device and an electric reading device |
11/14/2013 | WO2013166585A1 Detection and recovery of chemical elements from fluids with tectrabrachion |
11/14/2013 | WO2013138487A8 Liquid sampling device for use with mobile device and methods |
11/14/2013 | WO2013134689A9 A biochemical sensor for quantitative simultaneous multi-species bacteria detection in situ |
11/14/2013 | WO2013117930A3 Diagnosing multiple sclerosis |
11/14/2013 | WO2013105986A3 Devices, systems and methods for evaluation of hemostasis |
11/14/2013 | WO2013093644A3 Gene expression signatures for staging and prognosis of prostate, breast and leukemia cancers |
11/14/2013 | WO2013093512A3 Vaccine - screening method |
11/14/2013 | WO2013070953A8 Lysosomal enzyme assay methods and compositions |
11/14/2013 | WO2012109280A3 Apoe immunotherapy |
11/14/2013 | WO2012109157A3 Bioprobes and methods of use thereof |
11/14/2013 | WO2012082470A8 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer |
11/14/2013 | WO2012061744A3 Stabilized step function opsin proteins and methods of using the same |
11/14/2013 | WO2011005893A9 Biomarkers and methods for detecting alzheimer's disease |
11/14/2013 | WO2003039490A9 Compositions and methods for diagnosing and treating mental disorders |
11/14/2013 | WO2002088309A3 Fusion genes associated with acute megakaryoblastic leukemias |
11/14/2013 | US20130305397 Gene capable of regulating obesity/insulin sensitivity |
11/14/2013 | US20130304391 Transmission and compression of genetic data |
11/14/2013 | US20130304312 Diagnostic system and diagnosing method, housing component of a lubricant container |
11/14/2013 | US20130303984 Tissue penetration device |
11/14/2013 | US20130303960 Real-Time Adaptive Immune System and Method |
11/14/2013 | US20130303826 Prognostic signature for oral squamous cell carcinoma |
11/14/2013 | US20130303757 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
11/14/2013 | US20130303732 Method for using light scattering in real time to directly monitor and control impurity removal in purification processes |
11/14/2013 | US20130303573 Brown Adipocyte Progenitors in Human Skeletal Muscle |
11/14/2013 | US20130303570 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
11/14/2013 | US20130303530 Methods for treating chronic pelvic pain syndrome with antibodies that binds mcp-1 or mip-1a |
11/14/2013 | US20130303512 Use of modulators of CCR5 in the treatment of Cancer and cancer metastasis |
11/14/2013 | US20130303484 Prodrugs of Modulators of ABC Transporters |
11/14/2013 | US20130303439 Chimeric peptides including a penetrating peptide and a binding domain of pp2a catalytic subunit to caspase-9 |
11/14/2013 | US20130303408 Assemblies for multiplex binding assays |
11/14/2013 | US20130303405 Method for manufacturing an analysis substrate, and use thereof for detecting toxins |
11/14/2013 | US20130303404 High resolution dna detection methods and devices |
11/14/2013 | US20130303401 Systems and methods for diagnosing renal cell carcinoma |
11/14/2013 | US20130303398 Use and identification of biomarkers for gastrointestinal diseases |
11/14/2013 | US20130303396 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
11/14/2013 | US20130303395 Marker sequences for systemic lupus erythematosus and the use thereof |
11/14/2013 | US20130303393 Immunoglobulin libraries |
11/14/2013 | US20130303391 Methods for diagnosis and prognosis of inflammatory bowel disease using cytokine profiles |
11/14/2013 | US20130303380 Identification of ligands and their use |
11/14/2013 | US20130302911 Composition for detecting proteins containing tyrosine oxide-coupled biomaterial |
11/14/2013 | US20130302909 Assessment of igf-1 levels in hiv-infected subjects and uses thereof |
11/14/2013 | US20130302908 Thermostable Proteins and Methods Making and Using Thereof |
11/14/2013 | US20130302907 Method of assaying antigen and reagent therefor |
11/14/2013 | US20130302845 Measuring biological tissue |
11/14/2013 | US20130302841 Prognosis and risk assessment of patients with non-specific complaints |
11/14/2013 | US20130302838 Biomarker for amyloid-b-related neurological disorders |
11/14/2013 | US20130302837 Immunoassay for Direct Determination of Antigen Content of Products Comprising Adjuvant-Coupled-Antigen Particles |
11/14/2013 | US20130302835 ANTIBODIES DIRECTED AGAINST PYROGLUTAMATE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1 N1pE) |
11/14/2013 | US20130302834 Method for evaluating regenerated cartilage |
11/14/2013 | US20130302833 Method for control of invasion and use of adiponectin |
11/14/2013 | US20130302831 Methods and kits for detecting and diagnosing neurotrauma |
11/14/2013 | US20130302830 Rotors for immunoassays |
11/14/2013 | US20130302829 Method for predicting the response to her2-directed therapy |
11/14/2013 | US20130302827 Annexin-based apoptosis markers |
11/14/2013 | US20130302825 Uses of macrophage mannose receptor to screen compounds and uses of these compounds |
11/14/2013 | US20130302824 Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
11/14/2013 | US20130302821 Method For Evaluating Atherosclerotic Lesion, And Kit |
11/14/2013 | US20130302820 Methods and Compositions for Treating Bleeding Disorders |
11/14/2013 | US20130302819 Method for the early identification and prediction of an abrupt reduction in kidney function in a patient undergoing cardiothoracic surgery |
11/14/2013 | US20130302817 Functionalized Microfluidic Device And Method |
11/14/2013 | US20130302813 CELL WALL PROTEIN CwpV (CD0514) AS A DIAGNOSTIC MARKER FOR CLOSTRIDIUM DIFFICILE RIBOTYPE 027 |
11/14/2013 | US20130302809 Plurality of Reaction Chambers in a Test Cartridge |
11/14/2013 | US20130302808 Predicting cancer outcome |
11/14/2013 | US20130302805 Methods for removal of specific seed tissue or structure for seed analysis |
11/14/2013 | US20130302800 Tumor suppressor gene p47ing3 |
11/14/2013 | US20130302797 Methods for diagnosing, prognosing, or theranosing a condition using rare cells |
11/14/2013 | US20130302796 Devices And Methods For Enrichment And Alteration Of Circulating Tumor Cells And Other Particles |
11/14/2013 | US20130302788 Rapid detection of analytes in liquid samples |
11/14/2013 | US20130302781 Analyte detection method |
11/14/2013 | US20130302406 Biomimetic Emulsions |
11/14/2013 | US20130302380 Agent for inducing interferon production containing lactic acid bacteria |
11/14/2013 | US20130302366 Conformationally Specific Viral Immunogens |
11/14/2013 | US20130302343 Modulators of il-12 and/or il-23 for the prevention or treatment of alzheimer's disease |
11/14/2013 | US20130302340 Human timp-1 antibodies |
11/14/2013 | US20130302339 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and or wnt |
11/14/2013 | US20130302334 Bcl-2-like protein 11 srm/mrm assay |
11/14/2013 | US20130302329 Diagnostic tests for immune reactivity with human endothelial cell growth factor |